SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-18-000863
Filing Date
2018-08-14
Accepted
2018-08-14 16:29:17
Documents
6
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q063018_10q.htm 10-Q 471333
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10q063018_ex31z1.htm EX-31.1 7299
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10q063018_ex31z2.htm EX-31.2 7608
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10q063018_ex32z1.htm EX-32.1 3504
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10q063018_ex32z2.htm EX-32.2 3137
6 IMAGE f10q06301810q1.jpg GRAPHIC 50994
  Complete submission text file 0001078782-18-000863.txt   563796
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 181018047
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1